TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Rate of dementia diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of Minimal Cognitive Impairment (MCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of cognitive impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change of Combined Symptom and Medication Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Interleukin (IL) 17-A levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Outcome of penile carcinoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Modified Total Neuropathy Scale (mTNS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Subjective Neurotoxicity Subscale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence rate of EBV driven PTLD
Endpoint domain: Mortality/survival
Primary endpoint: Incidence rate of infections requiring hospitalisation
Endpoint domain: Adverse events/effects
Primary endpoint: Mortality rate in patients with persistent EBV DNAemia
Endpoint domain: Mortality/survival
Primary endpoint: Expression of costimulatory molecules CD86, CD80, CD40 and class II (HLA-DR) on monocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: myocardial glucose suppression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: bladder diary parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Technical Efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Incidence of restroke
Endpoint domain: Mortality/survival
Primary endpoint: ≥1 log10 rlu reduction in X4-tropic virus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: changes from baseline to Day 10 in log10 rlu corresponding to X4-tropic virus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Experienced Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Experienced Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Tolerated Dose of Romidepsin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Maximum Tolerated Dose of Lenalidomide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Maximum Tolerated Dose of Carfilzomib
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Data linkage
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in Sleep Fragmentation Index
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Adherence to Pulmonary Rehabilitation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in abdominal pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Tissue damage in the brain, spinal cord, and retinas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: The hospital for surgery score
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of 10 Most Common Cancers Associated Cases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of patients achieving ASAS20 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Re-experiencing Subscale (Criterion B)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Avoidance Subscale (Criterion C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hyperarousal (Criterion D)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Accuracy of blood glucose measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Carcinoembryonic antigen (CEA) serum level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Asia Pacific Colorectal Screening (APCS) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fecal immunochemical test (FIT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Venous Thromboembolism (VTE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Circulatory outcomes
Primary endpoint: Number of Participants With Arterial Thromboembolism (ATE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Circulatory outcomes
Primary endpoint: Falls per person
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Airway reactance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: steady-state pharmacokinetics (PK) of TPM XR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency and severity of toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Sensorial loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Tumor stage change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Continuing Pregnancy
Endpoint domain: Mortality/survival
Primary endpoint: Change in breast volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Serum concentrations of INH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Microstructural changes in the thalamus, corpus callosum and hippocampus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Continuous Nicotine Abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: invasive disease free survival (IDFS)
Endpoint domain: Mortality/survival
Primary endpoint: rate of patients undergoing antibiotic treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Accuracy of PCL diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of risk-stratification of IPMNs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Precision of sleep measurement
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Capsular Contracture Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Breast Q
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Understanding of key messages on stunting
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Carbon-dioxide partial pressure oscillations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean medicated diurnal IOP reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Number of participants with asthma and allergy characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: intraclass correlation coefficient (ICC) of MEP and SSEP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of acute rejection episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Sensitivity of CGM to detect coronary stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Specificity of CGM to detect coronary stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Positive predictive value (PPV) of CGM to detect coronary stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Negative predictive value (NPV) of CGM to detect coronary stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maintaining undetectable plasma HIV viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients maintaining a target trough plasma concentration of atazanavir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients displaying HIV strains with mutations associated to treatment resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Hamilton Depression Scale (HAMD-24)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: disability exam report quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cost comparison between tomotherapy and IMRT
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Local Disease Relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Aberrant Behavior Checklist score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Observed Spontaneous Bowel Movement Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in perceived vaginal odor
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: asthma or COPD treatment failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of relevant cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Risk of thromboembolic event based on the CHADS2 score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Risk of bleeding based on the HAS-BLED score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean Prescribed Budesonide Dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in pain of the amputated limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stride length on gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the Number of Conserved Elements (CEs) With a CD4 or a CD8 T Cell Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Occurrence of at Least One Greater Than or Equal to Grade 3 Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Median patency duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immune force
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: MRI T2 Mapping
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in tissue oxygenation/perfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in ischemic organ injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in hemolysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in NYHA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of Progression to Prostate Cancer
Endpoint domain: Mortality/survival
Primary endpoint: Change From Baseline in the Sum Score of Pruritus/Itch and Rash
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Changes in Memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of participants with 100% healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early postoperative vitreous haemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change in Headache Days/Month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve (AUC) Over One Dosing Interval for Diclofenac at Steady State
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Plasma Concentration During a Dosage Interval for Diclofenac at Steady State
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trendelenburg Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under The Plasma Concentration Versus Time Curve From Time 0 Extrapolated To Infinity (AUC0-inf)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time To Maximum Observed Plasma Concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cervical shortening measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Aspartate Aminotransferase (AST) / Alanine Aminotransferase (ALT) Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: CD4 Cell Count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Admission days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Functional differences of peri-prostatic adipose tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Exosomal small RNAs effect on cancer regulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Restoration survival over time
Endpoint domain: Mortality/survival
Primary endpoint: Mean Gastrointestinal Symptom Rating Scale (GSRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: 8-point blood glucose measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Alpha Frequency Electrical Activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fentanyl serum concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Determination of residual fentanyl content in the worn patches
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The skin adherence score of the patches
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of diagnostic tissue presence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pulmonary impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Sensitivity of Automatic Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: eradication rate of Neisseria gonorrhoeae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proper Glycemic Control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Humphrey Perimetry Visual Field
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes of the fMRI outcome after the treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mini-mental state examination (MMSE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Montreal Cognitive Assessment scale (MoCA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: All-cause mortality at 30-days after surgery
Endpoint domain: Mortality/survival
Primary endpoint: Myocardial injuries that were not identified clinically during the first 5 days after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite of vascular death, nonfatal myocardial infarction, nonfatal cardiac arrest, nonfatal stroke, and mechanical assist device
Endpoint domain: Mortality/survival
Primary endpoint: Staphylococcal and/or streptococcal count in milk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mass Balance Recovery of Total Radioactivity: CumAe (Total)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Archet scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Major Adverse Cardiac and Neurological Events (MACNE)
Endpoint domain: Adverse events/effects
Primary endpoint: GI Side Effects
Endpoint domain: Adverse events/effects
Primary endpoint: Ratio of tests ordered per patient-day
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Eating validation scheme score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MAI score (Medication Appropriateness Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean nighttime blood pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Achieving BP target at end of study
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Identification of causal pathogenic organism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Drug sensitivity test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: HAQ (Health Assessment Questionnaire)-Disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: HIV replication in cervical tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: number of immune cells in cervical tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: T cell subtype ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Norepinephrine requirements to maintain mean arterial blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Correctness in exercise performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance degree
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Treatment satisfaction: numerical visual scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Lenses Graded as 0 or 1 for Lens Centration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time interval to response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time interval to remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the Interleukin-6 Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Participants Experiencing Major Mobility Disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The slope of the rate-of-force development scaling factor (RFD-SF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor Evoked Potentials (MEP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Blood plasma oxytoxin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved psychosis/anxiety symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improved DANVA-2/NEPSY-2/social interaction scores
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in perfusion by Laser speckle contrast imaging (LSCI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in erythema by Antera 3D camera and 2D camera
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in temperature by thermography in celsius
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Oral Mucositis (OM) Severity Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of Oral Mucositis (OM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of Life post Radiation
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in objective physical activity (PA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in self-reported physical activity (PA)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Amount of breast milk expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Duration of breast feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Exclusive breast feeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nutritional outcomes
Primary endpoint: Number of Participants That Reported a Serious Adverse Event
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants That Reported a Non Serious Adverse Event Above 5 Percent Threshold
Endpoint domain: Adverse events/effects
Primary endpoint: Pulmonary graft dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Composite Endpoint of Cardiovascular Death or First Heart Failure Hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Change in Fibroblast Growth Factor 21 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Motor Activity Log - 14 Item Version
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning